Euthyroid sick syndrome and nutritional status are correlated with hyposelenemia in hemodialysis patients

International Journal of Artificial Organs

Volumn 34, Issue 7, 2011, Pages 577-583

  Liu, Mao Lin ^a   Xu, Gang ^a   Huang, Zi Yan ^a   Zhong, Xiao Chun ^a   Liu, Su Hang ^a   Jiang, Ting Ying ^a  

^a HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Endocrine metabolic dysfunction; Euthyroid sick syndrome; Hemodialysis; Nutritional status; Selenium

Indexed keywords

ABSORPTION SPECTROSCOPY; ATOMIC ABSORPTION SPECTROMETRY; BODY FLUIDS; HEMODIALYZERS; HORMONES; METABOLISM; NUTRITION; PHYSIOLOGY; SELENIUM; TRACE ELEMENTS;

CONTROL SUBJECT; ENDOCRINE-METABOLIC DYSFUNCTION; EUTHYROID SICK SYNDROME; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONE LEVELS; PARATHYROID HORMONES; SERUM LEVELS; THYROID HORMONES; THYROID STIMULATING HORMONES;

DIALYSIS;

ALBUMIN; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; SELENIUM; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; EUTHYROID SICK SYNDROME; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERLIPIDEMIA; HYPOLIPEMIA; IMMUNORADIOMETRIC ASSAY; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PARATHYROID HORMONE BLOOD LEVEL; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREMIA;

EID: 79961055468     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/IJAO.2011.8474     Document Type: Article

References (33)

1. Carrero JJ, Qureshi AR, Axelsson J, et al. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med. 2007;262(6):690-701. Medline. doi:10.1111/j.1365-2796.2007.01865.x
2. Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: a new facet of infammation in end-stage renal disease. J Am Soc Nephrol. 2005;16(9):2789-2795. Medline. doi:10.1681/ASN.2005040356
3. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;67(3):1047-1052. Medline. doi:10.1111/j.1523-1755.2005.00169.x
4. Jaroszyński AJ, Głowniak A, Chrapko B, et al. Low-T3 syndrome and signal - averaged ECG in haemodialysed patients. Physiol Res. 2005;54(5):521-526.
5. Lim VS. Thyroid function in patients with chronic renal failure. Am J Kidney Dis. 2001;38(4 Suppl 1):S80-S84. Medline. doi:10.1053/ajkd.2001.27410
6. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizini P. Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 2006;70(3):523-528.
7. Enia G, Panuccio V, Cutrupi S, et al. Subclinical hypothy-roidism is linked to micro-infammation and predicts dearth in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2007;22(2):538-544. Medline. doi:10.1093/ndt/ gf605
8. Liu ML, Huang ZY, Zhong XC, Liu SH, Xu G, Jiang TY. Th1 polarization and low T3 syndrome are correlated with hyperleptinaemia in hemodialysis patients. J Nephrol. 2009;22(4):515-522.
9. Fernández-Reyes MJ, Sánchez R, Heras M, et al. Can FT3 levels facilitate the detection of infammation or ca-tabolism and malnutrition in dialysis patients? Nefrologia. 2009;29(4):304-310.
10. Rucker D, Thadhani R, Tonelli M. Trace element status in he-modialysis patients. Semin Dial. 2010;23(4):389-395. Med-line. doi:10.1111/j.1525-139X.2010.00746.x
11. Apostolidis NS, Panoussopoulos DG, Stamou KM, et al. Selenium metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2002;22(3):400-404.
12. Bonomini M, Albertazzi A. Selenium in uremia. Artif Organs. 1995;19(5):443-448. Medline. doi:10.1111/j.1525-1594.1995. tb02357.x
13. Levander OA. Considerations on the assessment of selenium status. Fed Proc. 1985;44(9):2579-2583.
14. Kalantarzadeh K, Kopple JD. Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther. 2003;10(3):170-182. Medline. doi:10.1053/j. arrt.2003.09.002
15. Bogye G, Tompos G, Alfthan G. Selenium depletion in hemodi-alysis patients treated with polysulfone membranes. Nephron. 2000;84(2):119-123. Medline. doi:10.1159/000045558
16. Zachara BA. Mammalian selenoproteins. J Trace Elem Electrolytes Health Dis. 1992;6(3):137-151.
17. Burk RF, Hill KE. Some properties of selenoprotein P. Biol Trace Elem Res. 1992;33:151-153. Medline. doi:10.1007/ BF02784004
18. Deagen JT, Beilstein MA, Whanger PD. Chemical forms of selenium in selenium containing proteins from human plasma. J Inorg Biochem. 1991;41(4):261-268. Medline. doi:10.1016/0162-0134(91)80018-D
19. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;67(3):1047-1052. Medline. doi:10.1111/j.1523-1755.2005.00169.x
20. Bello G, Ceaichisciuc I, Silva S, Antonelli M. The role of thyroid dysfunction in the critically ill:a review of the literature. Minerva Anestesiol. 2010;76(11):919-928.
21. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501-509. Medline. doi:10.1056/NEJM200102153440707
22. Berry MJ, Banu L, Larsen PR. Type I iodothyronine de-iodinase is a selenocysteine-containing enzyme. Nature. 1991;349(6308):438-440. Medline. doi:10.1038/349438a0
23. Angstwurm MW, Schopohl J, Gaertner R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol. 2004;151(1):47-54. Medline. doi:10.1530/eje.0.1510047
24. Bianco AC, Salvatore D, Gereben B, Berrs MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23(1):38-89. Medline. doi:10.1210/er.23.1.38
25. Köhrle J. Local activation and inactivation of thyroid hormones:the deiodinase family. Mol Cell Endocrinol. 1999; 151 (1-2): 103-119. Medline. doi:10.1016/S0303-7207(99)00040-4
26. Bates JM, Spate VL, Morris JS, St Germain DL, Galton VA. Effects of selenium deficiency on tissue selenium content, deiodinase activity, and thyroid economy in the rat during development. Endocrinology. 2000;141(7):2490-2500. Med-line. doi:10.1210/en.141.7.2490
27. Warner MH, Beckett GJ. Mechanisms behind the non-thyroi-dal illness syndrome: an update. J Endocrinol. 2010;205(1):1-13. Medline. doi:10.1677/JOE-09-0412
28. Gärtner R. Selenium and thyroid hormone axis in critical ill states: an overview of conficting view points. J Trace Elem Med Biol. 2009;23(2):71-74. Medline. doi:10.1016/j. jtemb.2009.01.001
29. Berger MM, Lemarchand-Béraud T, Cavadini C, Chi-oléro R. Relations between the selenium status and the low T3 syndrome after major trauma. Intensive Care Med. 1996;22(6):575-581. Medline. doi:10.1007/BF01708099
30. Van Lente F, Daher R. Plasma selenium concentrations in patients with euthyroid sick syndrome. Clin Chem. 1992;38(9):1885-1888.
31. Berger MM, Reymond MJ, Shenkin A, et al. Infuence of selenium supplements on the post-traumatic alterations of the thyroid axis:a placebo-controlled trial. Intensive Care Med. 2001;27(1):91-100. Medline. doi:10.1007/ s001340000757
32. Jung CH, Sung KC, Shin HS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid pro-fle, hsCRP, and waist hip ratio in Korea. Korean J Intern Med. 2003;18(3):146-153.
33. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. J Intern Med. 2006;260(1):53-61. Medline. doi:10.1111/j.1365-2796.2006.01652.x